Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
0-14 |
MPA |
denotes |
CSF reactivity |
T1 |
18-32 |
GENE |
denotes |
GABAA receptor |
T2 |
42-75 |
CPA |
denotes |
encephalitis - Immunocytochemical |
T3 |
57-88 |
MPA |
denotes |
Immunocytochemical distribution |
T4 |
114-144 |
GENE |
denotes |
y-aminobutyric acid A receptor |
T5 |
146-152 |
GENE |
denotes |
GABAAR |
T6 |
154-166 |
REG |
denotes |
participates |
T7 |
175-203 |
CPA |
denotes |
neurophysiological processes |
T8 |
205-214 |
VAR |
denotes |
Mutations |
T9 |
215-220 |
REG |
denotes |
cause |
T10 |
221-229 |
DISEASE |
denotes |
epilepsy |
T11 |
234-262 |
CPA |
denotes |
neuropsychiatric pathologies |
T12 |
282-294 |
DISEASE |
denotes |
encephalitis |
T13 |
300-319 |
MPA |
denotes |
refractory seizures |
T14 |
343-350 |
GENE |
denotes |
GABAARs |
T15 |
360-369 |
REG |
denotes |
described |
T16 |
395-415 |
MPA |
denotes |
subunit distribution |
T17 |
419-426 |
GENE |
denotes |
GABAARs |
T18 |
428-435 |
INTERACTION |
denotes |
binding |
T19 |
454-460 |
GENE |
denotes |
GABAAR |
T20 |
500-515 |
CPA |
denotes |
pathophysiology |
T21 |
610-620 |
MPA |
denotes |
reactivity |
T22 |
646-658 |
DISEASE |
denotes |
encephalitis |
T23 |
755-761 |
GENE |
denotes |
GABAAR |
T24 |
778-794 |
MPA |
denotes |
immunoreactivity |
T25 |
812-815 |
CPA |
denotes |
CSF |
T26 |
816-822 |
REG |
denotes |
showed |
T27 |
833-842 |
REG |
denotes |
agreement |
T28 |
868-874 |
GENE |
denotes |
GABAAR |
T29 |
880-890 |
MPA |
denotes |
expression |
T30 |
892-906 |
INTERACTION |
denotes |
Colocalization |
T31 |
912-938 |
CPA |
denotes |
neuronal and glial markers |
T32 |
939-947 |
REG |
denotes |
verified |
T33 |
976-982 |
GENE |
denotes |
GABAAR |
T34 |
1003-1011 |
POSREG |
denotes |
strongly |
T35 |
1012-1017 |
INTERACTION |
denotes |
bound |
T36 |
1021-1029 |
CPA |
denotes |
neuropil |
T37 |
1132-1146 |
CPA |
denotes |
granular cells |
T38 |
1166-1178 |
MPA |
denotes |
Distribution |
T39 |
1188-1195 |
REG |
denotes |
suggest |
T40 |
1200-1208 |
REG |
denotes |
presence |
T41 |
1227-1233 |
GENE |
denotes |
GABAAR |
T42 |
1245-1254 |
REG |
denotes |
targeting |
T43 |
1325-1333 |
REG |
denotes |
revealed |
T44 |
1367-1378 |
REG |
denotes |
differences |
T45 |
1415-1426 |
POSREG |
denotes |
accumulated |
T46 |
1430-1439 |
CPA |
denotes |
dendrites |
T47 |
1451-1458 |
REG |
denotes |
created |
T48 |
1473-1488 |
MPA |
denotes |
neuropil signal |
T49 |
1504-1522 |
CPA |
denotes |
GABAergic synapses |
T50 |
1540-1548 |
POSREG |
denotes |
exceeded |
T51 |
1645-1652 |
REG |
denotes |
stained |
T52 |
1682-1699 |
CPA |
denotes |
GABAergic neurons |
T53 |
1710-1718 |
REG |
denotes |
indicate |
T54 |
1723-1731 |
REG |
denotes |
presence |
T55 |
1746-1774 |
CPA |
denotes |
anti-neuronal autoantibodies |
T56 |
1782-1785 |
CPA |
denotes |
CSF |
T57 |
1802-1810 |
REG |
denotes |
assessed |
T58 |
1934-1947 |
MPA |
denotes |
pathogenicity |
T59 |
1959-1966 |
REG |
denotes |
explain |
T60 |
1976-1993 |
CPA |
denotes |
clinical pictures |
T61 |
1997-2020 |
DISEASE |
denotes |
autoimmune encephalitis |
R0 |
T2 |
T0 |
ThemeOf |
encephalitis - Immunocytochemical,CSF reactivity |
R1 |
T0 |
T3 |
ThemeOf |
CSF reactivity,Immunocytochemical distribution |
R10 |
T5 |
T8 |
ThemeOf |
GABAAR,Mutations |
R11 |
T7 |
T6 |
ThemeOf |
neurophysiological processes,participates |
R12 |
T8 |
T9 |
CauseOf |
Mutations,cause |
R13 |
T10 |
T9 |
ThemeOf |
epilepsy,cause |
R14 |
T11 |
T9 |
ThemeOf |
neuropsychiatric pathologies,cause |
R15 |
T12 |
T15 |
ThemeOf |
encephalitis,described |
R16 |
T13 |
T15 |
ThemeOf |
refractory seizures,described |
R17 |
T14 |
T15 |
ThemeOf |
GABAARs,described |
R18 |
T16 |
T18 |
ThemeOf |
subunit distribution,binding |
R19 |
T17 |
T16 |
ThemeOf |
GABAARs,subunit distribution |
R2 |
T1 |
T0 |
ThemeOf |
GABAA receptor,CSF reactivity |
R20 |
T17 |
T18 |
ThemeOf |
GABAARs,binding |
R21 |
T17 |
T20 |
ThemeOf |
GABAARs,pathophysiology |
R22 |
T19 |
T16 |
ThemeOf |
GABAAR,subunit distribution |
R23 |
T19 |
T18 |
ThemeOf |
GABAAR,binding |
R24 |
T19 |
T20 |
ThemeOf |
GABAAR,pathophysiology |
R25 |
T22 |
T21 |
ThemeOf |
encephalitis,reactivity |
R26 |
T24 |
T26 |
ThemeOf |
immunoreactivity,showed |
R27 |
T24 |
T27 |
ThemeOf |
immunoreactivity,agreement |
R28 |
T25 |
T24 |
ThemeOf |
CSF,immunoreactivity |
R29 |
T25 |
T26 |
ThemeOf |
CSF,showed |
R3 |
T1 |
T2 |
ThemeOf |
GABAA receptor,encephalitis - Immunocytochemical |
R30 |
T25 |
T27 |
ThemeOf |
CSF,agreement |
R31 |
T25 |
T29 |
ThemeOf |
CSF,expression |
R32 |
T27 |
T26 |
ThemeOf |
agreement,showed |
R33 |
T28 |
T24 |
ThemeOf |
GABAAR,immunoreactivity |
R34 |
T28 |
T27 |
ThemeOf |
GABAAR,agreement |
R35 |
T28 |
T29 |
ThemeOf |
GABAAR,expression |
R36 |
T29 |
T27 |
ThemeOf |
expression,agreement |
R37 |
T30 |
T32 |
ThemeOf |
Colocalization,verified |
R38 |
T31 |
T30 |
ThemeOf |
neuronal and glial markers,Colocalization |
R39 |
T31 |
T32 |
ThemeOf |
neuronal and glial markers,verified |
R4 |
T1 |
T3 |
ThemeOf |
GABAA receptor,Immunocytochemical distribution |
R40 |
T33 |
T30 |
ThemeOf |
GABAAR,Colocalization |
R41 |
T33 |
T32 |
ThemeOf |
GABAAR,verified |
R42 |
T35 |
T34 |
ThemeOf |
bound,strongly |
R43 |
T36 |
T35 |
ThemeOf |
neuropil,bound |
R44 |
T36 |
T34 |
ThemeOf |
neuropil,strongly |
R45 |
T37 |
T34 |
ThemeOf |
granular cells,strongly |
R46 |
T37 |
T35 |
ThemeOf |
granular cells,bound |
R47 |
T38 |
T39 |
ThemeOf |
Distribution,suggest |
R48 |
T38 |
T40 |
ThemeOf |
Distribution,presence |
R49 |
T38 |
T42 |
ThemeOf |
Distribution,targeting |
R5 |
T2 |
T3 |
ThemeOf |
encephalitis - Immunocytochemical,Immunocytochemical distribution |
R50 |
T40 |
T39 |
ThemeOf |
presence,suggest |
R51 |
T40 |
T42 |
ThemeOf |
presence,targeting |
R52 |
T41 |
T38 |
ThemeOf |
GABAAR,Distribution |
R53 |
T41 |
T39 |
ThemeOf |
GABAAR,suggest |
R54 |
T41 |
T40 |
ThemeOf |
GABAAR,presence |
R55 |
T41 |
T42 |
ThemeOf |
GABAAR,targeting |
R56 |
T46 |
T45 |
ThemeOf |
dendrites,accumulated |
R57 |
T48 |
T47 |
ThemeOf |
neuropil signal,created |
R58 |
T49 |
T50 |
ThemeOf |
GABAergic synapses,exceeded |
R59 |
T52 |
T51 |
ThemeOf |
GABAergic neurons,stained |
R6 |
T4 |
T6 |
ThemeOf |
y-aminobutyric acid A receptor,participates |
R60 |
T54 |
T53 |
ThemeOf |
presence,indicate |
R61 |
T55 |
T53 |
ThemeOf |
anti-neuronal autoantibodies,indicate |
R62 |
T55 |
T54 |
ThemeOf |
anti-neuronal autoantibodies,presence |
R63 |
T56 |
T55 |
ThemeOf |
CSF,anti-neuronal autoantibodies |
R64 |
T55 |
T57 |
ThemeOf |
anti-neuronal autoantibodies,assessed |
R65 |
T56 |
T53 |
ThemeOf |
CSF,indicate |
R66 |
T56 |
T54 |
ThemeOf |
CSF,presence |
R67 |
T56 |
T57 |
ThemeOf |
CSF,assessed |
R68 |
T60 |
T59 |
ThemeOf |
clinical pictures,explain |
R69 |
T61 |
T58 |
ThemeOf |
autoimmune encephalitis,pathogenicity |
R7 |
T4 |
T7 |
ThemeOf |
y-aminobutyric acid A receptor,neurophysiological processes |
R70 |
T61 |
T59 |
ThemeOf |
autoimmune encephalitis,explain |
R71 |
T61 |
T60 |
ThemeOf |
autoimmune encephalitis,clinical pictures |
R8 |
T5 |
T6 |
ThemeOf |
GABAAR,participates |
R9 |
T5 |
T7 |
ThemeOf |
GABAAR,neurophysiological processes |